165 related articles for article (PubMed ID: 16784842)
1. Synthesis and evaluation of phenoxy acetic acid derivatives as [corrected] anti-mycobacterial agents.
Shaharyar M; Siddiqui AA; Ali MA
Bioorg Med Chem Lett; 2006 Sep; 16(17):4571-4. PubMed ID: 16784842
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.
Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2010 Aug; 45(8):3384-8. PubMed ID: 20488590
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives.
Liu YX; Xiao CL; Wang YX; Li YH; Yang YH; Li YB; Bi CW; Gao LM; Jiang JD; Song DQ
Eur J Med Chem; 2012 Jun; 52():151-8. PubMed ID: 22503208
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Pagadala LR; Mukkara LD; Singireddi S; Singh A; Thummaluru VR; Jagarlamudi PS; Guttala RS; Perumal Y; Dharmarajan S; Upadhyayula SM; Ummanni R; Basireddy VS; Ravirala N
Eur J Med Chem; 2014 Sep; 84():118-26. PubMed ID: 25016370
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
7. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents.
Raju BC; Rao RN; Suman P; Yogeeswari P; Sriram D; Shaik TB; Kalivendi SV
Bioorg Med Chem Lett; 2011 May; 21(10):2855-9. PubMed ID: 21507635
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties.
Karabasanagouda T; Adhikari AV; Shetty NS
Eur J Med Chem; 2007 Apr; 42(4):521-9. PubMed ID: 17156898
[TBL] [Abstract][Full Text] [Related]
10. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents.
Upadhayaya RS; Vandavasi JK; Kardile RA; Lahore SV; Dixit SS; Deokar HS; Shinde PD; Sarmah MP; Chattopadhyaya J
Eur J Med Chem; 2010 May; 45(5):1854-67. PubMed ID: 20137835
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides.
Johar M; Manning T; Kunimoto DY; Kumar R
Bioorg Med Chem; 2005 Dec; 13(24):6663-71. PubMed ID: 16140016
[TBL] [Abstract][Full Text] [Related]
13. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.
Alvey L; Prado S; Huteau V; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Bioorg Med Chem; 2008 Sep; 16(17):8264-72. PubMed ID: 18752967
[TBL] [Abstract][Full Text] [Related]
14. Oxadiazole mannich bases: synthesis and antimycobacterial activity.
Ali MA; Shaharyar M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3314-6. PubMed ID: 17467984
[TBL] [Abstract][Full Text] [Related]
15. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
[TBL] [Abstract][Full Text] [Related]
17. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
Sriram D; Yogeeswari P; Senchani G; Banerjee D
Bioorg Med Chem Lett; 2007 Apr; 17(8):2372-5. PubMed ID: 17376679
[TBL] [Abstract][Full Text] [Related]
18. New agents with antimycobacterial activity.
Marco-Contelles J; Gómez-Sánchez E
Arch Pharm (Weinheim); 2005 Nov; 338(11):562-3. PubMed ID: 16281303
[TBL] [Abstract][Full Text] [Related]
19. Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ring.
Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS
Drug Des Discov; 1994 Jan; 11(1):73-89. PubMed ID: 7520762
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis.
Menendez C; Rodriguez F; Ribeiro AL; Zara F; Frongia C; Lobjois V; Saffon N; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2013 Nov; 69():167-73. PubMed ID: 24016834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
